// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "WARRANTY STANDARDS disease organism part MAY OR AC PRM mass TIP CELL PS HTML source name_ and _assay name IS MT WILL ... EFO INFRINGE COLUMN PSI MONDO LC NOT ALL CLO XML CV ENVO PROTEOMICS PO README EBI TA PRIDE:0000659 MS CN EW OF III PEPTIDESEQ ID CT DJ CF VK disease stage characteristics MHC LIMITED cell type REQUIRED DDA MAJOR BTO CS HANCESTRO HUPO data file cleavage agent details COULD alkylation reagent NCE URL RIGHTS sex DIA DOID depletion TAB MS:1001251 NOTE REQUIRES IAA exclamation MOD CPTAC SDRF SHALL PARTICULAR age SWATH dissociation method HCD MC RFC SRM instrument NCBI MIAME FITNESS fractionation method RECOMMEND PURPOSE URI ROW FOR PATCH organism SP IMPLIED VCF JA RECOMMENDED technical replicate ZFA QY spiked compound DISCLAIMS HEREIN MAGE NT THE ISA fraction identifier INFORMATION II MINOR PMID INCLUDING RAW PP EM FDR WARRANTIES SH replicate collision energy BRENDA IMPORTANT ANY individual PATO PTM pooled sample biosample accession number MUST HF EXPRESS developmental stage DTT UBERON PMCID TMT reduction reagent SN sample CL AS INITIATIVE TO label XL BMC BUT IDF MERCHANTABILITY CID OPTIONAL ancestry category source name SHOULD USE PRIDE THAT LI SILAC BE proteomics data acquisition method biological replicate file your"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "WARRANTY STANDARDS disease organism part MAY OR AC PRM mass CELL PS HTML IS MT WILL ... EFO INFRINGE COLUMN PSI MONDO LC NOT ALL CLO CV ENVO PROTEOMICS PO README EBI TA PRIDE:0000659 MS CN EW OF III PEPTIDESEQ CT DJ CF VK disease stage MHC LIMITED cell type REQUIRED DDA MAJOR BTO CS HANCESTRO HUPO data file cleavage agent details COULD alkylation reagent NCE URL RIGHTS sex DIA DOID depletion TAB MS:1001251 REQUIRES IAA MOD CPTAC SDRF SHALL PARTICULAR age SWATH dissociation method HCD MC RFC SRM instrument NCBI MIAME FITNESS fractionation method RECOMMEND PURPOSE URI ROW FOR PATCH organism SP IMPLIED VCF JA RECOMMENDED technical replicate ZFA QY spiked compound DISCLAIMS HEREIN MAGE NT THE ISA fraction identifier INFORMATION II MINOR PMID INCLUDING RAW PP EM FDR WARRANTIES SH collision energy BRENDA ANY individual PATO PTM pooled sample biosample accession number MUST HF EXPRESS DTT UBERON PMCID TMT reduction reagent SN CL AS INITIATIVE TO label XL BMC BUT IDF MERCHANTABILITY CID OPTIONAL ancestry category SHOULD USE PRIDE THAT LI SILAC BE proteomics data acquisition method biological replicate"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "lib disease organism part MAY CL:0000576 APP CL:0000084 TIP UBERON:0002113 CL:0000235 EFO CL:0000625 PATO:0001340 CL:0000057 MONDO ALL PDX PO PATO:0000384 CL:0000066 CL:0000623 CL:0000813 MONDO:0004975 UBERON:0001977 CL:0000788 ID UBERON:0000310 MONDO:0100096 UBERON:0000178 MONDO:0005105 cell type enrichment process HANCESTRO CSF CL:0000540 URL sex DOID depletion disease model MONDO:0004946 NOTE exclamation NSG SDRF age CL:0000233 NCBI CL:0000451 MONDO:0005138 MONDO:0005301 UBERON:0001088 CL:0000624 organism MONDO:0004989 UBERON:0000955 CL:0000232 xenograft CML MONDO:0005180 DSS MONDO:0005575 compound MONDO:0005148 UBERON:0002107 CL:0000236 IMPORTANT CL:0000815 individual CL:0000787 CL:0000913 PATO PTM UBERON:0001359 UBERON:0002097 NK UBERON:0001155 MUST developmental stage UBERON PATO:0000461 CL synthetic peptide CL:0000898 COVID UBERON:0002048 UBERON:0000948 ancestry category source name PATO:0000383 SHOULD UBERON:0001969 MONDO:0008383 CL:0000182 biological replicate"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "disease organism part MAY CL:0000576 APP CL:0000084 UBERON:0002113 CL:0000235 EFO CL:0000625 PATO:0001340 CL:0000057 MONDO ALL PDX PO PATO:0000384 CL:0000066 CL:0000623 CL:0000813 MONDO:0004975 UBERON:0001977 CL:0000788 ID UBERON:0000310 MONDO:0100096 UBERON:0000178 MONDO:0005105 cell type enrichment process HANCESTRO CSF CL:0000540 URL sex DOID depletion disease model MONDO:0004946 NSG SDRF age CL:0000233 NCBI CL:0000451 MONDO:0005138 MONDO:0005301 UBERON:0001088 CL:0000624 organism MONDO:0004989 UBERON:0000955 CL:0000232 xenograft CML MONDO:0005180 DSS MONDO:0005575 compound MONDO:0005148 UBERON:0002107 CL:0000236 CL:0000815 individual CL:0000787 CL:0000913 PATO PTM UBERON:0001359 UBERON:0002097 NK UBERON:0001155 MUST developmental stage UBERON PATO:0000461 CL synthetic peptide CL:0000898 COVID UBERON:0002048 UBERON:0000948 ancestry category source name PATO:0000383 SHOULD UBERON:0001969 MONDO:0008383 CL:0000182 biological replicate"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "disease body mass index organism part gestational age NCIT:C16358 NCIT:C27966 NCIT:C81327 EFO NCIT:C62723 MONDO NCIT:C4870 NCIT:C15632 NCIT:C71732 ER HANCESTRO:0009 NCIT:C15445 pre-existing condition NCIT:C53556 BMI NCIT III ID NCIT:C18213 treatment disease stage PREFERRED diet alcohol consumption NCIT:C27970 weight pregnancy status NCIT:C15262 HANCESTRO CHEBI:41774 PD NCIT:C14167 NCIT:C28078 sex ethnicity NOTE NCIT:C15329 NCIT:C14168 medication history HANCESTRO:0010 exclamation MONDO:0005300 SDRF age NCIT:C18206 MONDO:0011122 NCI dose NCIT:C28077 NCIT:C53554 ACE menopausal status NCIT:C28054 GDPR NCIT:C68804 organism NCIT:C81328 HANCESTRO:0005 NCIT:C53555 treatment response NCIT:C65107 treatment status NCIT:C28076 tumor grade NCIT:C18058 II CHEBI:28748 UO TNM smoking status Ann Arbor stage MONDO:0004995 compound MONDO:0005148 MONDO:0002050 PR IMPORTANT individual NCIT:C14169 time post treatment NCIT:C53553 HIPAA CHEBI:6801 NCIT:C27971 NCIT:C65108 Dukes stage MONDO:0005044 height AJCC breast cancer subtype TNM staging NCIT:C28079 CHEBI:27899 ancestry category HANCESTRO:0006 prior treatment NCIT:C15313 IV NCIT:C65106 secondary condition sampling time point NCIT:C14174 MONDO:0004979"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "disease body mass index organism part gestational age NCIT:C16358 NCIT:C27966 NCIT:C81327 EFO NCIT:C62723 MONDO NCIT:C4870 NCIT:C15632 NCIT:C71732 ER HANCESTRO:0009 NCIT:C15445 pre-existing condition NCIT:C53556 BMI NCIT III ID NCIT:C18213 treatment disease stage PREFERRED diet alcohol consumption NCIT:C27970 weight pregnancy status NCIT:C15262 HANCESTRO CHEBI:41774 PD NCIT:C14167 NCIT:C28078 sex ethnicity NCIT:C15329 NCIT:C14168 medication history HANCESTRO:0010 MONDO:0005300 SDRF age NCIT:C18206 MONDO:0011122 NCI dose NCIT:C28077 NCIT:C53554 ACE menopausal status NCIT:C28054 GDPR NCIT:C68804 organism NCIT:C81328 HANCESTRO:0005 NCIT:C53555 treatment response NCIT:C65107 treatment status NCIT:C28076 tumor grade NCIT:C18058 II CHEBI:28748 UO TNM smoking status Ann Arbor stage MONDO:0004995 compound MONDO:0005148 MONDO:0002050 PR individual NCIT:C14169 time post treatment NCIT:C53553 HIPAA CHEBI:6801 NCIT:C27971 NCIT:C65108 Dukes stage MONDO:0005044 height AJCC breast cancer subtype TNM staging NCIT:C28079 CHEBI:27899 ancestry category HANCESTRO:0006 prior treatment NCIT:C15313 IV NCIT:C65106 secondary condition sampling time point NCIT:C14174 MONDO:0004979"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "UNIMOD:1 IMPORTANT MS:1001303 LTQ RPPA proteomexchange accession number MS:1001309 PRIDE:0000663 MGF UNIMOD UNIMOD:35 scan window lower limit instrument PRM AC URI REQUIRED DDA MUST TIP HF CS MRM fragment mass tolerance MT KR TMT file uri UNIMOD:4 precursor mass tolerance data file RECOMMENDED PSI technical replicate sample TS cleavage agent details FTP MS:1001313 fraction URL label XL NT DIA UNIMOD:21 MS:1001917 fraction identifier MM NOTE TA MS2 analyzer type MS exclamation SHOULD ST SILAC RAW SDRF SCIEX PRIDE PP MOD MSD ID ELISA TOF MS1 scan range MS:1001306 CF SRM UNIMOD:737 MS:1001251 proteomics data acquisition method scan window upper limit modification parameters"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "UNIMOD:1 MS:1001303 LTQ RPPA proteomexchange accession number MS:1001309 PRIDE:0000663 MGF UNIMOD UNIMOD:35 scan window lower limit instrument PRM AC URI REQUIRED DDA MUST HF CS fragment mass tolerance MRM MT KR TMT file uri UNIMOD:4 precursor mass tolerance data file RECOMMENDED PSI technical replicate TS cleavage agent details FTP MS:1001313 URL label XL NT DIA UNIMOD:21 MS:1001917 fraction identifier MM TA MS2 analyzer type MS SHOULD ST SILAC RAW SDRF SCIEX PRIDE PP MOD MSD ID ELISA TOF MS1 scan range MS:1001306 CF SRM UNIMOD:737 MS:1001251 proteomics data acquisition method scan window upper limit modification parameters"
  }
];
